Fusion inhibitors can effectively inhibit the infection of SARS-CoV-2 variants and other human coronaviruses, their broad-spectrum effect is based on the fact that the spike protein (S protein) responsible for viral entry plays a key role in viral infections, and the HR-1 domain is highly conserved region between coronaviruses [57,58,59]. Here, PROS1 is linked to infection.